Summary An analysis of cytology reporting within Victorian Cytology Service demonstrates that the proportion of Papanicolaou smears which were reported as including an endocervical component increased from approximately one half during 1987-89 to more than three quarters during . The improvement coincided with the routine provision of special sampling instruments to all practitioners supplemented by an education program. Despite the increase in endocervical sampling, no increase in the rate of reporting of high-grade intraepithelial lesions of the cervix has occurred. An increase between the two time periods in the cytological reporting of adenocarcinoma, adenocarcinoma in situ and endocervical dyskaryosis has occurred, but does not reach statistical significance.
The late 1980s was a time when renewed emphasis was given to the quality of the cell sample for cervical cytology specimens. A number of studies had documented a higher abnormality rate among smears which included an endocervical component than among smears which were reported as lacking an endocervical component (Elias et al., 1983; Laverty et al., 1989; Mauney & Sotham, 1990; Vooijs et al., 1986) . As a consequence, many laboratories devoted considerable time and resources to strategies aimed at increasing the proportion of smears with an endocervical component.
In Australia it became routine for laboratories to provide practitioners with sampling instruments which were specifically designed to facilitate collecting an endocervical sample. Practitioners were informed there were two reasons for the change. First, a higher detection rate of abnormalities was expected, hopefully reducing the false negative rate of screening. Second, improved detection of the precursors to adenocarcinoma was anticipated.
Victorian Cytology Service is the largest cytology laboratory in Australia, reporting periods, 1987-1989 and 1990-1991 comprehensive detection of abnormalities occurred. This study, based on an analysis of more than one million Papanicolaou smears reported over 5 years, has shown that despite a very substantial increase in the proportion of smears with an endocervical component, no commensurate increase in the reporting of high-grade intraepithelial lesions of the cervix occurred. The declining ratio of reported abnormalities in smears with and without an endocervical component indicates a weakening of the relationship between endocervical status and the probability of an abnormality being reported. These findings suggests that the more likely explanation of the association between endocervical component and higher abnormality rate was that a relatively easily sampled endocervical component was a marker of women who were at higher risk of abnormality.
A number of randomised trials have recently been conducted evaluating different sampling instruments with the outcome measure of interest being the rate of cytological reporting of dyskaryosis. Four randomised trials (Goorney et al., 1989; Buxton et al., 1990; Selvaggi & Malviya, 1991; Szarewski et al., 1990) have demonstrated an increase in the proportion of smears with an endocervical component but no commensurate increase in the detection of intraepithelial abnormalities. Wolfendale et al. (1987) showed an increase in the sampling of endocervical material and, while a increase in the crude rate of reporting of dyskaryotic smears was noted, when account was taken of the design of the study, no statistically significant increase in the detection of abnormalities was found. Overall the findings from these randomised trials support the findings of this current study; that is, that there may not be a commensurate increase in the reporting of intraepithelial abnormalities despite an increase in the endocervical sampling rate. Conclusions by Boon et al. (1989) about higher detection rates of intraepithelial neoplasia with different sampling instruments have been considered invalid by Sasieni (1991 Sasieni ( , 1992 because of flawed statistical analyses.
Over the time period of this study, the age of the women being screened by VCS did not alter to any appreciable extent; 82%-84% of smears in each year were received from women under 50 years of age. Similarly there is no evidence that the failure to show an increased reporting of high grade intraepithelial abnormalities was due to a decline in the quality of the sample of the anatomical ectocervix. Table IV shows the proportion of all smears which were reported as unsatisfactory for assessment in each of the calendar years of this study plus gives details of the number of smears which were reported as being unsatisfactory because of insufficient squamous cells. The data show that the proportion of smears reported as being unsatisfactory has declined over the period of this study.
The introduction of the new sampling instruments and the educational program for practitioners was not without cost, both in financial terms and in the use of human resources. Substantial efforts were needed to inform practitioners about how to collect a Papanicolaou smear using two instruments without suffering a deterioration in the quality of the specimen; cervical cells deteriorate rapidly after collection and there was a need to ensure that the fixation of both specimens was adequate. Many practitioners wished to use two glass slides, one for each specimen. This was considered highly undesirable as it would result in a doubling of the number of slides to be processed.
From the laboratory's viewpoint, the new policy had a number of effects. An internal retraining program was necessary for cytologists as they were unfamiliar with the full range of appearances of endocervical samples obtained using a brush. Even the requirement that all specimens have their endocervical status reported was associated with a slowing of work throughput. Perhaps more intangibly there was a disruption to the general level of confidence among the cytologists which was particularly apparent during 1988. The fact that other laboratories were reporting very much high proportions of all smears as including an endocervical component raised concerns about the false negative rate among our numerically large group of smears which lacked an endocervical component. In addition VCS cytologists were aware that other laboratories were reporting up to 15% of their smears as showing evidence of human papillomavirus effect; the comparable figure within VCS was approximately 4%. These concerns resulted in a change in reporting practice whereby more minor changes were reported as abnormal which would previously have been regarded as being within normal limits. These uncertainties probably account for the statistics for 1988 being noticeably different to the general trend. By 1989 the laboratory had, to a large extent, resumed its more long-standing profile of reporting (Mitchell & Medley, 1990) .
Clearly the two reasons for advocating the change in policy to practitioners have not been fulfilled. The increase in the reporting of endocervical abnormalities may be clinically important but does not yet reach statistical significance. Adenocarcinoma of the cervix is a rare disease among the premenopausal age group which comprises the majority of participants in the screening program in Australia (Free et al., 1991) . We have previously shown that the sensitivity of cervical cytology for the detection of adenocarcinoma is less than for squamous carcinoma (Mitchell et al., 1988) . A worthwhile benefit of the changed policies will be if the accuracy of predicting disease of the endocervix improves, particularly the detection of endocervical dyskaryosis and adenocarcinoma in situ. Continued monitoring in these areas is occurring.
